50+ molecules of various types developed
Category: *CDMO
Exhibitor: ATON (SHANGHAI) BIOTECH CO., LTD.
Booth No: N/A
Characteristic
Aton has the ability to develop different types of complex structures at various clinical stages, and has successfully constructed 50+ molecules, of which 5 monoclonal antibodies have successfully obtained commercialization approvals.
Other Products
Highest Rated Products